First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-01-01
DOI
https://doi.org/10.1136/jitc-2024-010565
Citations
10
Primary Topic
Phagocytosis and Immune Regulation
Type
article
Field-Weighted Citation Impact
7.97
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer

Erika Hamilton, Nehal J. Lakhani, Daphne Stewart, Elliot Offman et al.
10 citations
Journal for ImmunoTherapy of Cancer
Phagocytosis and Immune Regulation
7.97
article

First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer

Erika Hamilton, Nehal J. Lakhani, Daphne Stewart, Elliot Offman, Linda Van Le, Justin Call, Simon Metenou, Lini Pandite, Jade Huguet, Lauren Dockery, Fatima Rangwala, Guanfang Wang, Debra L. Richardson, Bo Ma
article en
10 citations

Abstract

No abstract available for this paper.
Journal for ImmunoTherapy of CancerVol. 13(1)
University of North Carolina at Chapel Hill (US), Lemuel Shattuck Hospital (US), Sarah Cannon (US), City of Hope (US), South Texas Accelerated Research Therapeutics (US), Start Treatment & Recovery Centers (US), University of Oklahoma (US)
Good health and well-being
Openalex Percentile: Top 2%
Phagocytosis and Immune Regulation
7.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer — Erika Hamilton, Nehal J. Lakhani, et al. · Journal for ImmunoTherapy of Cancer (2025) | TGRS Research Map | TGRS